Two Consecutive Sunscreen Applications Optimize Sun Protection
NCT ID: NCT03033654
Last Updated: 2017-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2015-02-28
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Assess the Effectiveness of Sunscreen on Oil Control, Moisturization, and Skin Barrier Integrity in Adults With Oily Skin
NCT06616558
The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects
NCT03065582
Multiday Beach Study
NCT03041064
Evaluate the Photoprotection Efficiency of Sunscreen Formulas Under Visible Light Exposure
NCT06796088
Determine the Photoprotection Efficacy of Seven Sunscreen Products Under Visible Light Exposure.
NCT06796179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Two Consecutive Sunscreen Applications
Sunscreen, Actinica
Two Consecutive Sunscreen Applications
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sunscreen, Actinica
Two Consecutive Sunscreen Applications
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ida M. Heerfordt
MD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-1-2014-094
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.